Announcements  by unknown
Electronic Submission
Deadline for submission is October 10, 2003. Please submit your
abstract via the World Wide Web. All abstract submissions must
be in the structured format as required by The Journal of Thoracic
and Cardiovascular Surgery. The structured abstract is to contain
the following major headings: Objective(s), Methods, Results, and
Conclusions, and it should clearly reflect the content of the com-
pleted paper. No reference should be made on the abstract to the
names or institutions of the authors.
Receipt of each abstract will be acknowledged by e-mail, fax,
or mail. Notification of the decision of the Program Committee
will be distributed by January 9, 2004.
Essayists selected for the program are reminded that papers
presented at the meeting are to be submitted for consideration for
publication to The Journal of Thoracic and Cardiovascular Sur-
gery and must be handed to the Chair immediately prior to their
presentation.
C. Walton Lillehei Resident Forum
The C. Walton Lillehei Resident Forum will be held on Tuesday
morning, April 27, 2004. Made possible through an educational
grant from St Jude Medical, the Forum will consist of the
presentation of original work by residents in thoracic surgical
training programs around the world. Abstracts submitted for the
award should follow the guidelines of abstract submission for
electronic submission noted above. The abstracts submitted for
consideration for this Forum will be evaluated by the Program
Committee and eight will be selected for presentation during the
forum. Each of the selected authors will receive round-trip
travel and accommodations for the duration of the AATS annual
meeting. Additionally, one presentation will be selected by the
Program Committee to receive the AATS C. Walton Lillehei
Residents’ Award, a $5000 prize. Thoracic Surgery Program
Directors are urged to have their residents participate in this
Forum.
Abstract Deadlines—Abstracts received after the deadline
will not be considered
Electronic Submission Only: October 10, 2003
Applications for Membership
Applications for membership in the Association must be received
by the Membership Committee Chairman no later than October 3,
2003. Applications received after that date will be deferred auto-
matically for consideration until the 2005 meeting.
Applicants must be sponsored by three Active or Senior
Members of the Association who are not members of the
Membership Committee. Requests for membership applications
may be sent to:
Chairman, Membership Committee
American Association for Thoracic Surgery
900 Cummings Center
Suite 221-U
Beverly, MA 01915
978-927-8330; fax: 978-524-8890
e-mail: aats@prri.com
Tirone E. David, MD, Secretary
The Western Thoracic
Surgical Association
Announcement of 2003 Annual Meeting
The Twenty-ninth Annual Meeting of The Western ThoracicSurgical Association will be held June 18-21, 2003, at LaCosta Resort and Spa in Carlsbad, California. The scientific
sessions are open to all duly qualified physicians. Participation in
other Association activities for members, invited guests, and program
participants will require payment of a social registration fee.
Requests for Meeting Information
Meeting preregistration and hotel registration forms are available
from:
The Western Thoracic Surgical Association
900 Cummings Center
Suite 221-U
Beverly, MA 01915
978-927-8330; fax: 978-524-8890
wtsa@prri.com
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PROGRAM FOR 2003 ANNUAL MEETING
29th Annual Meeting
June 18-21, 2003
La Costa Resort, Carlsbad, California
Preliminary Program
WEDNESDAY, JUNE 18, 2003
3:00 PM Registration Opens
7:00 PM New Members Reception, Poolside
THURSDAY, JUNE 19, 2003
6:00 AM Samson Fun Run
7:00 AM Registration—Conference Center Foyer
Continental Breakfast—Exhibit Hall, Poinsettia I
8:00 AM Introduction of New Members and Resident Essay Finalists, Poinsettia II-III
8:10 AM SCIENTIFIC SESSION (10 minutes presentation, 10 minutes discussion), Poinsettia II-III
Moderators: Edward D. Verrier and Robert C. Robbins
1. Transmyocardial Revascularization Versus Medical Therapy: Five-Year Follow-Up of a
Prospective Randomized Trial
Keith B. Allen, MD,* Robert D. Dowling, MD,* William W. Angell, MD, and Deepak M. Gangahar,
MD,* St Vincent Medical Center—Indianapolis, Ind
2. Inhaled Prostacyclin Is a Safe and Effective Alternative to Nitric Oxide for Treatment of
Pulmonary Hypertension and Right Ventricular Failure After Cardiothoracic Surgery
David G. Affleck, MD,* Eric Jacobsohn, MBChB, MHPE,* Laureen L. Hill, MD,* Charl J. DeWet,
MMBCh,* Michael S. Avidan, MBChB,* Heidi A. Tymkew, MHS,* Marc R. Moon, MD,* Ralph J.
Damiano, MD,* and Nader Moazami, MD,* Washington University School of Medicine—St Louis,
Mo
3. Comparison of Bilateral Thoracic Grafting With Percutaneous Coronary Interventions in
Patients With Diabetes Mellitus
Cham Locker, MD,* Rephael Mohr, MD,* Oren Levran, MD,* Gideon Uretzky, MD,* Aharon
Frimerman, MD,* Tael Shahar, MD,* and Itzhak Shapira, MD,* Tel Aviv Souraky Medical Center—
Tel Aviv, Israel
9:10 AM PRESIDENTIAL ADDRESS
Edward D. Verrier, Seattle, Wash
10:00 AM Coffee Break—Visit Exhibits, Poinsettia I
10:30 AM SCIENTIFIC SESSION (10 minutes presentation, 10 minutes discussion), Poinsettia II-III
Moderators: R. Scott Mitchell and Vaughn A. Starnes
†4. Seven-Year Experience With Aortic Arch Reconstruction: Safety of Moderate Hypothermia
With Antegrade Cerebral Perfusion During Systemic Circulatory Arrest
Richard C. Cook,* Nancy Day, RN,* Lynn Fedoruk, MD,* and Michael T. Janusz, MD,* University
of British Columbia—Vancouver, BC, Canada
*By Invitation
†Samson Resident Prize Essay
1190 The Journal of Thoracic and Cardiovascular Surgery ● May 2003
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5. Thoracic Surgical Procedures in Patients Enrolled in a CT Screening Trial
Juan A. Crestanello, MD,* Mark S. Allen, MD,* James Jett, MD,* Staphen D. Cassivi, MD,* Francis
C. Nichols III, MD,* Stephen J. Swensen, MD,* Claude Deschamps, MD,* and Peter C. Pairolero,
MD,* Mayo Clinic—Rochester, Minn
6. Early Cavopulmonary Anastomosis Is Safe in Very Young Infants After the Norwood
Procedure
Robert D. B. Jaquiss, MD,* Nancy S. Ghanayem, MD,* George M. Hoffman, MD,* Raymond T.
Fedderly, MD,* Joseph R. Cava, MD,* Kathleen A. Mussatto, RN, BSN,* and James S. Tweddell,
MD,*
Medical College of Wisconsin—Milwaukee, Wis
7. Minimally Invasive Technology for Mitral Valve Surgery via Left Thoracotomy: Experience
With 34 Cases
Paul C. Saunders, MD,* Eugene A. Grossi, MD,* Ram Sharony, MD,* Charles F. Schwartz, MD,*
Greg H. Ribakove, MD,* Julie Delianides, RN,* Aubrey C. Galloway, MD,* and Stephen B. Colvin,
MD,* New York University Medical Center—New York, NY
11:50 AM CONTROVERSIES IN THORACIC SURGERY
“The NETT Trial: Now We Have Data”
Moderator: Richard I. Whyte
“Results of Open Versus Thoracoscopic Surgical Operations for Lung Volume Reduction”
TBD
“Medical versus Surgical Treatment of End-Stage Pulmonary Failure”
TBD
“Was the NETT Trial Worth the Wait?”
TBD
PANEL DISCUSSION
12:30 PM Adjourn
7:00 PM Theme Dinner
La Costa Pavillion
FRIDAY, JUNE 20, 2003
6:30 AM SIMULTANEOUS BREAKFAST SESSIONS
A. Adult Cardiac Session
Marigold Room
Destination LVAD Therapy
James W. Long
Are There Patients That Need and Want Long-Term LVAD Support?
TBD
B. General Thoracic Session
Iris I Room
Neoadjuvant Therapy for Esophageal Carcinoma
Pro: Jeffrey A. Hagen
Con: Richard I. Whyte
*By Invitation
Announcements
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 5 1191
C. Congenital Heart Disease Session
Iris II Room
Treatment of Adult Congenital Heart Disease
Medical Treatment
Joseph K. Perloff
Surgical Treatment
TBD
7:00 AM Continental Breakfast—Exhibit Hall, Poinsettia I
8:00 AM POSTGRADUATE COURSE
Sponsored by: White Memorial Medical Center and Foundation—Lyman A. Brewer, III Fund
Poinsettia II-III
Introduced by: Edward D. Verrier
“Cell Transplantation to Prevent Heart Failure”
Richard D. Weisel, Toronto, Ontario, Canada
8:50 AM SCIENTIFIC SESSION (10 minutes presentation, 10 minutes discussion), Poinsettia II-III
Moderators: David A. Bull and John D. Mitchell
8. Angiogenic Pretreatment Enhances Transplanted Cardiomyocyte Survival and Efficacy of the
Cellular Cardiomyoplasty in a Myocardial Infarct Model
Todd K. Rosengart, MD,* Mauricio A. Retuerto, MD,* Paul Schalch, MD,* Gerald Patejunas, PhD.*
JoAnn Carbray, BS,* Naxin Liu, PhD,* Leslie McGregor, BS,* and Ronald G. Crystal, MD,*
Evanston Northwestern Healthcare—Evanston, Ill
9. Is Extensive Total Arch Replacement for Acute Aortic Dissection Justified?
Kenji Minatoya, MD,* Hitoshi Ogino, MD,* Hiroaki Sasaki, MD,* Toshikatsu Yagihara, MD,* and
Soichiro Kitamura, MD,* National Cardiovascular Center—Suita, Osaka, Japan
†10. Toll-Like Receptor 4 (FLR4) Mediates Ischemia-Reperfusion Injury in the Heart
Albert J. Chong, MD,* Craig R. Hampton, MD,* Akira Shimamoto, MD, PhD,* Christine L.
Rothnie, BS,* Denise J. Spring, PhD,* Timothy H. Pohlman, MD,* and Edward D. Verrier, MD,*
University of Washington—Seattle, Wash
11. The Impact of Barrett’s Esophagus on Outcomes for Adenocarcinoma
Michael F. Reed, MD,* Barish H. Edil, MD,* George Tolis, Jr, MD,* James S. Allan, MD,*
Donahue M. Dean, MD,* Ashby C. Moncure, MD,* John C. Wain, MD,* Cameron D. Wright, MD,*
and Douglas J. Mathisen, MD,* Massachusetts General Hospital—Boston, Mass
†12. Propensity Case-Matched Analysis of a Six-Year Experience With Minimally Invasive Isolated
Aortic Valve Replacement
Ram Sharony, MD,* Eugene A. Grossi, MD,* Paul C. Saunders, MD,* Charles F. Schwartz, MD,*
Greg H. Ribakove, MD,* Patricia Ursomanno, RN,* Aubrey C. Galloway, MD,* and Stephen B.
Colvin, MD,* New York University Medical Center—New York, NY
10:30 AM Coffee Break—Visit Exhibits, Poinsettia I
11:00 AM SCIENTIFIC SESSION (10 minutes presentation, 10 minutes discussion), Poinsettia II-III
Moderators: John C. Chen and Scot H. Merrick
*By Invitation
†Samson Resident Prize Essay
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13. Initial Clinical Trial of Pulmonary Vein Isolation With Bipolar Radiofrequency for the
Treatment of Atrial Fibrillation
Sydney L. Gaynor, MD,* Marc R. Moon, MD,* Sunil M. Prasad, MD,* Samuel A. Wickline, MD,*
Kara M. Barnett, BA,* Nicholas R. Damiano,* Marci S. Bailey, RN,* Rachel L. Herren, RN,*
Yosuke Ishii, MD,* Richard B. Schuessler, PhD,* and Ralph J. Damiano, Jr, MD,* Washington
University School of Medicine—St Louis, Mo
†14. Does Septal-Lateral Annular Cinching Work for Chronic Ischemic Mitral Regurgitation?
Frederick A. Tibayan, MD,* Filiberto Rodriguez, MD,* Frank Langer, MD,* Mary K. Zasio, BA,*
Lynn Bailey, BA,* David Liang, MD, PhD,* George T. Daughters, MS,* Neil B. Ingels, PhD,* and
D. Craig Miller, MD,* Stanford University—Stanford, Calif
15. Mechanical Connections for Distal Anastomosis in CABG Surgery: Initial Experience and
Clinical Results
Thierry Carrel, MD,* Lazs Englberger, MD,* Dorothee Keller, RN,* and Friedrich Eckstein, MD,*
University Hospital—Berne, Switzerland
12:00 PM Adjourn
AFTERNOON—GOLF AND TENNIS TOURNAMENTS
EVENING—FREE
SATURDAY, JUNE 21, 2003
7:00 AM Continental Breakfast—Exhibit Hall, Poinsettia I
7:30 AM POSTER FORUM SESSION (5 minutes presentation, 3 minutes discussion), Poinsettia II-III
Moderators: Edward D. Verrier and Irving L. Kron
P1. NF Kappa B Mediates Contralateral Lung Injury Following Reperfusion of Ischemic Lung
Yvonne Carter, MD,* Timothy Pohlman, MD,* Eric Vallieres, MD, Edward D. Verrier, MD, and
Riyad Karmy-Jones, MD,* UCSF Medical Center—San Francisco, Calif
P2. Combinatorial Gene Therapy of Interleukin-4 and 10 Promotes CD8 T Cells Apoptosis and
Prevents Cardiac Allograft Myocytes Apoptosis via Perforin/Granzyme B Pathway
Hiroshi Furukawa, MD,* Ryde Russell, MD,* Kiyohiro Oshima, MD,* Thomas Tung, MD,*
Guanggen Cui, MD,* Hillel Laks, MD, and Luyi Sen, MD,* UCLA Medical Center—Los Angeles,
Calif
P3. Role Of Activating Transcription Factor (ATF)-3 In Myocardial Ischemia-Reperfusion Injury
Akira Shimamoto, MD, PhD,* Albert J. Chong, MD,* Craig R. Hampton, MD,* Christine L.
Rothnie, BS,* Denise J. Spring, PhD,* Dan Lu, MS,* Tsonwin Hai, PhD,* Timothy H. Pohlman,
MD,* and Edward D. Verrier, MD, University of Washington—Seattle, Wash
P4. Novel Effects of Endothelin Antagonism on Cardial Allograft Recovery
Paul W. M. Fedak, MD,* Vivek Rao, MD, PhD,* Patty Boylen, MD,* Pedram Kazemian, MSc,*
Christopher Feindel, MD,* and Laura Tumiat, BSc,* Toronto General Hospital—Toronto, Ontario,
Canada
P5. Effects of Phoshorylcholine Coating on Extracorporeal Circulation Management and
Postoperative Outcome
Roberto Lorusso, MD, PhD,* Giulio Pavan, MD,* Gaetano Minzioni, MD,* and Pasquale Totaro,
MD,* Civic Hospital—Brescia, Italy
*By Invitation
†Samson Resident Prize Essay
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P6. Cavopulmonary Assist in the Newborn
Mark D. Rodefeld, MD,* Jack H. Boyd, MD,* Robert G. Presson, Jr, MD,* Wiltz W. Wagner, Jr,
PhD,* and John W. Brown, MD,* Indiana University School of Medicine—Indianapolis, Ind
P7. Matrix Metalloproteinase Activity in Thoracic Aneurysms Associated with Bicuspid and
Tricuspid Aortic Valves
Jon Boyum, MD,* Erika K. Fellinger, MD,* Joseph D. Schmoker, MD,* Lucy Trombly, MS,*
Kenneth McPartland, MD,* and Frank P. Ittleman, MD,* Fletcher Allen Health Care, University of
Vermont—Burlington, Vt
P8. A Decade of Living Lobar Transplantation: Perioperative Complications Following 253 Donor
Lobectomies
Michael E. Bowdish, MD,* Mark L. Barr, MD,* Felicia A. Schenkel, RN,* Robbin G. Cohen, MD,
Craig J. Baker, MD,* Marlyn S. Woo, MD,* Ross M. Bremner, MD,* Winfield J. Wells, MD, and
Vaughn A. Starnes, MD, University of Southern California—Los Angeles, Calif
8:30 AM SCIENTIFIC SESSION (10 minutes presentation, 10 minutes discussion), Poinsettia II-III
Moderators: David N. Campbell and Douglas E. Wood
†16. Coronary Artery Bypass With Ventricular Remodeling Is Superior to Coronary Artery Bypass
Alone in Patients With Ischemic Cardiomyopathy
Thomas S. Maxey, MD,* Brett Reece, MD,* John A. Kern, MD,* Curtis G. Tribble, MD,* and
Irving L. Kron, MD,* University of Virginia Health System—Charlottesville, Va
17. Aortic Root Replacement for Annuloaortic Ectasia: A 30-Year Experience
Kenton J. Zehr, MD,* Alireza Matloobi, MD,* Thomas A. Orszulak, MD,* Charles J. Mullany,
MD,* Richard C. Daly, MD,* Joseph A. Dearani, MD,* Thoralf M. Sundt, MD,* F. J. Puga, MD,*
Gordon K. Danielson, MD,* and Hartzell V. Schaff, MD,* Mayo Clinic—Rochester, Minn
†18. Neo-chordal Repair: A Simplified Approach to Correct Mitral Valve Prolapse Without Leaflet
Resection
John J. Nigro, MD,* Michael E. Bowdish, MD,* Daniel S. Schwartz, MD,* Candace Bart, MD,*
Mark J. Cunningham, MD,* Mark L. Barr, MD,* and Vaughn A, Starnes, MD, University of
Southern California—Los Angeles, Calif
19. Surgical Treatment of Paraesophageal Hiatal Hernia
Alex G. Little, MD, Dylan Curry, MD,* and Timothy Browder, MD,* University of Nevada School
of Medicine—Las Vegas, Nev
9:50 AM Coffee Break—Visit Exhibits, Poinsettia I
10:10 AM SCIENTIFIC SESSION (10 minutes presentation, 10 minutes discussion), Poinsettia II-III
Moderators: Robbin G. Cohen and Steven R. Gundry
20. Performance of Bioprostheses and Mechanical Prostheses Assessed by Composites of Valve-
Related Complications at 15 Years for Mitral Valve Replacement
W. R. Eric Jamieson, MD, Eva Germann, MSc,* Robert T. Miyagishima, MD, Lawrence H. Burr,
MD,* Michael T. Janusz, MD,* and Hilton Ling, MD,* University of British Columbia—Vancouver,
BC, Canada
21. Equivalent 5-Year Outcomes After Off-Pump and On-Pump Surgery
Joseph F. Sabik III, MD,* Eugene H. Blackstone, MD,* Bruce W. Lytle, MD,* A. Marc Gillinov,
MD,* Jose L. Navia, MD,* Penny L. Houghtaling, MD,* and Delos M. Cosgrove, MD,* The
Cleveland Clinic Foundation—Cleveland, Ohio
*By Invitation
†Samson Resident Prize Essay
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22. Five to Nine Year Results of Endovascular Repair of Descending Thoracic Aortic Aneuryms
With First-Generation Stent-Grafts
Philippe Demers, MD, PhD, FRASC,* D. Craig Miller, MD, R. Scott Mitchell, MD, Stephen T. Kee,
MD,* and Michael D. Dake, MD,* Stanford University Medical Center, Falk Research—Stanford,
Calif
11:10 AM C. WALTON LILLEHEI POINT/COUNTERPOINT SESSION, Poinsettia II-III
1Valvular Heart Disease Will Be Treated with Percutaneous Strategies Within Five Years
Moderator: Edward D. Verrier
Pro: TBD
Con: Stephen B. Colvin
12:00 AM ANNUAL BUSINESS MEETING (Members Only) Poinsettia II-III
12:30 PM LUNCHEON, ORCHID TERRACE AND LAWN
7:00 PM PRESIDENT’S RECEPTION AND BANQUET
Clubhouse Parlor and Veranda Rooms
*By Invitation
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